Supplementary Table 1.
Demographic and Clinical Features of Patients Included in the Study
| Clinical features | AIH (N = 71) | PBC (N = 67) |
|---|---|---|
| Female, n | 60 (84%) | 66 (98%) |
| Age, ya | 64 (21–87) | 63 (37–89) |
| Liver stiffness, kPaa | 6.2 (2.4–40.0) | 5.9 (2.3–39.5) |
| Liver stiffness, >10 kPa, n | 11 (15%) | 6 (9%) |
| CAP, dB/ma | 223 (137–366) | 204 (89–312) |
| CAP, >280 dB/m, n | 7 (10%) | 3 (4%) |
| Cirrhosis, n | 13 (18%) | 6 (9%) |
| Decompensated liver disease, n | 0 (0%) | 0 (0%) |
| Arterial hypertension, n | 27 (38%) | 24 (36%) |
| Diabetes mellitus, n | 14 (20%) | 7 (10%) |
| Obesity, n | 16 (22%) | 14 (21%) |
| Rheumatologic disease, n | 1 (1%)b | 10 (15%)c |
| Prednisone, mg/da | 6.25 (1.25–50) | – |
| Azathioprine, mg/da | 50 (25–125) | – |
| Vaccination for influenza, n | 7 (10%) | 5 (7%) |
| Job during COVID-19 pandemic | ||
| Working from home or unemployed, n | 62 (87%) | 64 (95%) |
| Medical doctor or nurse, n | 4 | 1 |
| Salesperson or cashier, n | 3 | 2 |
AIH, autoimmune hepatitis; CAP, controlled attenuation parameter; COVID-19, coronavirus disease 2019; PBC, primary biliary cholangitis.
a
Median (range).
b
Undifferentiated connective tissue disease.
c
Eight patients had systemic sclerosis, 1 patient had undifferentiated connective tissue disease, and 1 patient had systemic lupus erythematosus.